AQR Capital Management
CDLX icon

AQR Capital Management’s Cardlytics CDLX Stock Holding History

AQR Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,119
Closed -$91.9K – 2777
2024
Q2 		$91.9K Sell
1,119
-106
-9% -$11.5K ﹤0.01% 2502
2024
Q1 		$177K Buy
+1,225
New +$103K ﹤0.01% 2271
2021
Q4 		– Sell
-432
Closed -$363K – 2208
2021
Q3 		$363K Sell
432
-336
-44% -$341K ﹤0.01% 1984
2021
Q2 		$974K Sell
768
-154
-17% -$174K ﹤0.01% 1603
2021
Q1 		$1.01M Buy
922
+188
+26% +$248K ﹤0.01% 1544
2020
Q4 		$1.05M Sell
734
-232
-24% -$247K ﹤0.01% 1483
2020
Q3 		$681K Sell
966
-47
-5% -$34.2K ﹤0.01% 1601
2020
Q2 		$709K Sell
1,013
-427
-30% -$247K ﹤0.01% 1614
2020
Q1 		$503K Buy
1,440
+334
+30% +$237K ﹤0.01% 1585
2019
Q4 		$695K Buy
+1,106
New +$541K ﹤0.01% 1644

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AQR Capital Management's CDLX Position: Q3 2024 in Review

AQR Capital Management sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 1,119 shares — an estimated $91.9K sold.

AQR Capital Management first reported a position in CDLX in Q4 2019 and held it in 10 quarters. The position peaked at $1.05M in Q4 2020. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • AQR Capital Management reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
  • AQR Capital Management sold 1,119 Cardlytics shares in Q3 2024, an estimated $91.9K.
  • AQR Capital Management first reported a position in Cardlytics in Q4 2019 and held it in 10 quarters.
  • AQR Capital Management's Cardlytics position peaked at $1.05M in Q4 2020.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on AQR Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.